Picture of Crossject SA logo

ALCJ Crossject SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Crossject requests pharmaceutical status to ANSM

Oct 18 (Reuters) - Crossject SA  ALCJ.PA : 
    * Requests pharmaceutical status to ANSM (Agence Nationale de Sécurité du Médicament et des 
Produits de santé) 
    * This step will give Crossject more autonomy to develop its own drugs based on its 
self-needle injection device Zeneo 
 
Further company coverage:  ALCJ.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Crossject SA

See all news